DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Landstedt-Hallin L, Adamson U, Lins PE.
Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.
J Clin Endocrinol Metab 1999; 84: 3140-3145
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.